NL-OMON20140招募中不适用
ltra-high B-value diffusion weighted magnetic resonance imaging; the added value at 1.5T
Zuyderland Medical Centre, Heerlen, Netherlands0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •patients with increased PSA serum values, patients with known and proven prostate cancer, patients with benign prostate hyperplasia
排除标准
- •patients with contradictory medical, images with movement artifacts
研究者
相似试验
已完成
3 期
Effect of PMZ-2010 in Hypovolemic Shock patients.CTRI/2019/01/017196Pharmazz India Private Limited105
已完成
3 期
DB2116134: A randomized, multi-center, double-blind, double-dummy, parallel group study to evaluate the efficacy and safety of umeclidinium/vilanterol compared with fluticasone propionate/salmeterol over 12 weeks in subjects with COPDNL-OMON38572GlaxoSmithKline BV65
招募中
不适用
Effectiveness of supplementation of Nefrosave® in Chronic Kidney DiseaseCTRI/2020/04/024476Fourrts India Laboratories Pvt Ltd
尚未招募
3 期
postoperative paiCTRI/2019/02/017850Akums Drugs Pharmaceutical Ltd India
尚未招募
3 期
A multicentre, multinational, randomizedm Double-Blind, Placebo Controlled, crossover trial to evaluate efficacy and safety of Fentanyl TAIFUN ® treatment after titrated dose administration for breakthrough pain in cancer patients on maintenance opioid therapyCTRI/2009/091/000243Akela Pharma INC180